Ontology Development: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
===Current content work=== | ===Current content work=== | ||
*High Priority | *High Priority | ||
**[[:Category:Content PAMGO|PAMGO collaboration]] | |||
**[[Sensu Main Page]] | **[[Sensu Main Page]] | ||
**[[Function-Process Links]] | **[[Function-Process Links]] | ||
| Line 22: | Line 23: | ||
===Completed content work=== | ===Completed content work=== | ||
*[[Immunology Revisions]] | *[[Immunology Revisions]] | ||
*[[Central Nervous System Development]] | *[[Central Nervous System Development]] | ||
Revision as of 07:43, 25 January 2007
This group's purpose is to ensure that the Gene Ontology represents biology in a way that is useful for gene product annotation of reference genomes and other MODs using the GO for annotation. The group serves as the link between biological knowledge that is gained from wet-bench scientists and the representation of that knowledge in the GO. Members of the group are responsible for reporting areas of the GO that need development and for suggesting changes and additions to the GO as needs arise. Members of the group serve as biological experts in domains that are covered by their organism. They are responsible for reviewing changes to be sure that they accurately reflect our current understanding of biology.
Administrative
Content Development
Current content work
- High Priority
- Lower Priority
Future content work
- Response to drug
- Cardiovascular physiology/development
- Peripheral nervous system development
- Transport and transporters